Monitoring of hepatitis E virus in wastewater can identify clinically relevant variants [0.03%]
废水中的戊型肝炎病毒监测可识别具有临床相关性的病毒变异体
Fiona Rau,Carina Elsner,Toni Luise Meister et al.
Fiona Rau et al.
Hepatitis E virus (HEV) is prevalent worldwide and can cause persistent infection with severe morbidity. Antiviral treatment approaches can lead to the emergence of viral variants encoding escape mutations that may impede viral clearance. T...
Cost-effectiveness study of FIB-4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at-risk population [0.03%]
FIB-4紧接着瞬时弹性成像筛查策略在非酒精性脂肪肝高危人群中对晚期肝纤维化的成本效益研究
Huiyul Park,Eileen L Yoon,Mimi Kim et al.
Huiyul Park et al.
Background & aims: The cost-effectiveness to screen hepatic fibrosis in at-risk population as recommended by several professional societies has been limited. This study aimed to investigate the cost-effectiveness of this ...
Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022 [0.03%]
2022年全国调查：埃及乙型肝炎和丙型肝炎消除的证据
Amr Kandeel,Manal Fahim,Shimaa Abukamar et al.
Amr Kandeel et al.
Introduction: Viral hepatitis C (HCV) and B (HBV) were at the top of Egypt's most significant public health challenges, with an estimated 14.7% of its population having antibodies to HCV in 2008. Egypt issued an ambitious...
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC [0.03%]
晚期肝细胞癌患者中MASLD与阿特珠单抗-贝伐珠单抗治疗不良结局之间无相关性
Francisca-Dora Copil,Claudia Campani,Marie Lequoy et al.
Francisca-Dora Copil et al.
Introduction: It has been suggested that in patients with hepatocellular carcinoma (HCC) of metabolic aetiology, the efficacy of immunotherapy may be reduced. The aim was to investigate the impact of metabolic-associated ...
May we actually help clinicians select the best systemic treatment for patients with intermediate-stage hepatocellular carcinoma? [0.03%]
我们能否帮助临床医生选择最适合中间期肝细胞癌患者的系统治疗方案？
Edoardo G Giannini,Mario Strazzabosco
Edoardo G Giannini
Cell type-specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis [0.03%]
甲状腺激素在非酒精性脂肪肝炎和肝纤维化中的细胞类型特异性作用
Tobias Puengel,Frank Tacke
Tobias Puengel
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease [0.03%]
不同性别代谢功能障碍相关性脂肪肝患者酒精摄入量的差异
Yixuan Zhu,Xiaoming Xu,Zhiwen Fan et al.
Yixuan Zhu et al.
Background and aims: The relationship between moderate alcohol intake and health outcomes among individuals with metabolic dysfunction-associated fatty liver disease (MAFLD) is complex. Our aim was to investigate the asso...
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation [0.03%]
基于Transformer的微血管侵犯分类器可提升射频消融术后肝细胞癌预后分层的效果
Wentao Wang,Yueyue Wang,Danjun Song et al.
Wentao Wang et al.
Background & aims: We aimed to develop a Transformer-based deep learning (DL) network for prognostic stratification in hepatocellular carcinoma (HCC) patients undergoing RFA. ...
Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study [0.03%]
penetrance、癌症发生率和生存率在HFE血色病中的研究-基于人群的队列研究
Benedikt Schaefer,Lorenz M Pammer,Bernhard Pfeifer et al.
Benedikt Schaefer et al.
Background and aims: Haemochromatosis is characterized by progressive iron overload affecting the liver and can cause cirrhosis and hepatocellular carcinoma. Most haemochromatosis patients are homozygous for p.C282Y in HF...
Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study [0.03%]
与代谢功能障碍性脂肪肝病相关的甲状腺功能，脂肪因子和线粒体肽：一项基于多中心活检的观察研究
Matina Kouvari,Laura Valenzuela-Vallejo,Evangelos Axarloglou et al.
Matina Kouvari et al.
Background and aims: Thyroid axis is currently under investigation as a therapeutic target in metabolic dysfunction-associated steatotic liver disease (MASLD). Thyroid function was examined herein in the full spectrum of ...